Literature DB >> 11333876

Adaptation of chimeric retroviruses in vitro and in vivo: isolation of avian retroviral vectors with extended host range.

E V Barsov1, W S Payne, S H Hughes.   

Abstract

We have designed and characterized two new replication-competent avian sarcoma/leukosis virus-based retroviral vectors with amphotropic and ecotropic host ranges. The amphotropic vector RCASBP-M2C(797-8), was obtained by passaging the chimeric retroviral vector RCASBP-M2C(4070A) (6) in chicken embryos. The ecotropic vector, RCASBP(Eco), was created by replacing the env-coding region in the retroviral vector RCASBP(A) with the env region from an ecotropic murine leukemia virus. It replicates efficiently in avian DFJ8 cells that express murine ecotropic receptor. For both vectors, permanent cell lines that produce viral stocks with titers of about 5 x 10(6) CFU/ml on mammalian cells can be easily established by passaging transfected avian cells. Some chimeric viruses, for example, RCASBP(Eco), replicate efficiently without modifications. For those chimeric viruses that do require modification, adaptation by passage in vitro or in vivo is a general strategy. This strategy has been used to prepare vectors with altered host range and could potentially be used to develop vectors that would be useful for targeted gene delivery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333876      PMCID: PMC114900          DOI: 10.1128/JVI.75.11.4973-4983.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

1.  Effect of the Fv-1 locus in vivo: host range pseudotypes of murine sarcoma virus.

Authors:  J A Otten; F E Myer; R W Tennant; A Brown
Journal:  J Natl Cancer Inst       Date:  1978-04       Impact factor: 13.506

2.  Pseudotype particles of vesicular stomatitis virus with surface antigens of bovine leukaemia virus--VSV (BLV) -- as a sensitive probe for detecting antibodies in the sera of spontaneously infected cattle.

Authors:  J Závada; L Cerný; A D Altstein; Z Závadová
Journal:  Acta Virol       Date:  1978-03       Impact factor: 1.162

3.  Characterization of sarcoma-positive, leukemia-negative (S+L-) human cells induced by the feline leukemia virus pseudotype of Moloney sarcoma virus.

Authors:  J S Rhim
Journal:  Proc Soc Exp Biol Med       Date:  1981-09

4.  Restriction of host range of xenotropic pseudotype murine sarcoma virus by helper leukemia virus.

Authors:  T Okazaki
Journal:  Acta Med Okayama       Date:  1983-08       Impact factor: 0.892

5.  Neutralization of pseudotypes of vesicular stomatitis virus by sera from avian retrovirus-infected hosts.

Authors:  R Mandeville; P Rohan; M A Wainberg
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

6.  A novel strategy of cell targeting based on tissue-specific expression of the ecotropic retrovirus receptor gene.

Authors:  T Igarashi; S Suzuki; M Takahashi; T Tamaoki; T Shimada
Journal:  Hum Gene Ther       Date:  1998-12-10       Impact factor: 5.695

7.  Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.

Authors:  Z Závadová; J Závada
Journal:  Acta Virol       Date:  1980-05       Impact factor: 1.162

8.  Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae.

Authors:  L Gritz; J Davies
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

9.  The use of vesicular stomatitis (visna virus) pseudotypes to demonstrate visna virus receptors in cells from different species.

Authors:  D H Gilden; M Devlin; Z Wroblewska
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia.

Authors:  C D Scher
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  17 in total

1.  Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.

Authors:  René Daniel; James G Greger; Richard A Katz; Konstantin D Taganov; Xiaoyun Wu; John C Kappes; Anna Marie Skalka
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells.

Authors:  Changming Yu; Gennett M Pike; Tommy A Rinkoski; Cristina Correia; Scott H Kaufmann; Mark J Federspiel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

3.  Retroviral replicating vectors in cancer.

Authors:  Christopher R Logg; Joan M Robbins; Douglas J Jolly; Harry E Gruber; Noriyuki Kasahara
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

4.  Gα13 mediates human cytomegalovirus-encoded chemokine receptor US28-induced cell death in melanoma.

Authors:  Shripad Joshi; Christian Wels; Christine Beham-Schmid; Mizuho Fukunaga-Kalabis; Sheri L Holmen; Marcus Otte; Meenhard Herlyn; Maria Waldhoer; Helmut Schaider
Journal:  Int J Cancer       Date:  2015-03-16       Impact factor: 7.396

5.  Construction and characterization of a replication-competent retroviral shuttle vector plasmid.

Authors:  Jangsuk Oh; John G Julias; Andrea L Ferris; Stephen H Hughes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors.

Authors:  Kevin W Chang; Eugene V Barsov; Andrea L Ferris; Stephen H Hughes
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.

Authors:  Dimitri Lavillette; Alessia Ruggieri; Bertrand Boson; Marielle Maurice; François-Loïc Cosset
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

Authors:  Christopher R Logg; Brian T Baranick; Nathan A Lemp; Noriyuki Kasahara
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

10.  Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides.

Authors:  Robin Chan; Pradeep D Uchil; Jing Jin; Guanghou Shui; David E Ott; Walther Mothes; Markus R Wenk
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.